Related Experiment Video
Updated: Feb 25, 2026

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Cancer Immunotherapy, Part 3: Challenges and Future Trends
Abstract:
Despite dramatic breakthroughs, obstacles remain for the field of immunotherapy in cancer. These include the inability to predict treatment efficacy and patient response; the need for improved biomarkers; the development of resistance to immunotherapies; the lack of optimized clinical study designs; and high costs. Are solutions in sight?
Insights
Immunotherapy for cancer shows promise but faces challenges like predicting patient response and overcoming resistance. Ongoing research aims to address these hurdles for better treatment outcomes.
Area of Science:
- Oncology
- Immunology
- Biomedical Research
Background:
- Cancer immunotherapy has advanced significantly, offering new treatment avenues.
- Despite breakthroughs, critical challenges impede widespread clinical success and patient benefit.
Purpose of the Study:
- To identify and discuss the primary obstacles hindering the efficacy and application of cancer immunotherapy.
- To explore potential solutions and future directions for overcoming current limitations in the field.
Main Methods:
- Literature review of recent advancements and challenges in cancer immunotherapy.
- Analysis of key issues including predictive biomarkers, treatment resistance, clinical trial design, and cost-effectiveness.
Main Results:
- Key challenges include predicting treatment efficacy, identifying reliable biomarkers, and managing acquired resistance.
- Suboptimal clinical study designs and high treatment costs further complicate immunotherapy implementation.
Conclusions:
- Solutions are being actively sought through innovative research and strategic development.
- Addressing these multifaceted challenges is crucial for realizing the full potential of cancer immunotherapy.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer

